Salt Lake City, UT, United States of America

Michael S Kay

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: University of Utah Research Foundation, Navigen, Inc., The United States of America—air Force. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael S Kay. Retrieved from https://idiyas.com/inventor/michael-s-kay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 2)

% Patents Active = 85.7

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)

Company Filing History:

7 out of 1,685

University of Utah Research Foundation

The United States of America—air Force

patent

where one patent can have more than one assignee

Years Active: 2016-2021

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11020482 - Methods and compositions related to inhibition of viral entry (2021-06-01),

2. 10765754 - Compositions and methods related to inhibition of respiratory syncytial virus entry (2020-09-08),

3. 10512665 - Methods and compositions related to inhibition of viral entry (2019-12-24),

4. 10487121 - D-peptide inhibitors of HIV entry and methods of use (2019-11-26),

5. 10406229 - Methods and compositions related to inhibition of viral entry (2019-09-10),

6. 10189878 - Ebolavirus pre-hairpin intermediate mimics and methods of use (2019-01-29),

7. 9381226 - Methods and compositions related to inhibition of viral entry (2016-07-05),

Title: Michael S Kay: Innovator in Viral Inhibition

Introduction

Michael S Kay is a prominent inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of viral inhibition, holding a total of 7 patents. His work focuses on developing methods and compositions that inhibit viral entry, which is crucial for advancing medical treatments.

Latest Patents

Among his latest patents, Kay has disclosed innovative methods and compositions related to the inhibition of viral entry. One notable patent addresses the inhibition of respiratory syncytial virus (RSV) entry into host cells. This patent also includes methods for identifying peptides that interact with the N-trimer of the RSV F protein, showcasing his commitment to tackling viral infections.

Career Highlights

Throughout his career, Michael S Kay has worked with esteemed organizations such as the University of Utah Research Foundation and Navigen, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Brett D Welch and J Nicholas Francis. Their collaborative efforts have further enhanced the impact of Kay's research and innovations.

Conclusion

Michael S Kay's contributions to the field of viral inhibition through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in medical science and treatment options.

Profile summary based on public USPTO records.